Nikko Asset Management Americas’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-22,100
Closed -$1.7M 226
2017
Q4
$1.7M Hold
22,100
0.04% 137
2017
Q3
$1.7M Buy
22,100
+1,900
+9% +$145K 0.08% 127
2017
Q2
$1.57M Sell
20,200
-1,900
-9% -$136K 0.09% 137
2017
Q1
$1.59M Sell
22,100
-100
-0.5% -$6.91K 0.12% 101
2016
Q4
$1.38M Buy
+22,200
New +$1.36M 0.11% 103

Other funds holding RMD

Nikko Asset Management Americas's RMD Position: Q1 2018 in Review

Nikko Asset Management Americas sold out of ResMed (RMD) in Q1 2018, closing a stake of 22,100 shares — an estimated $1.7M sold.

Nikko Asset Management Americas first reported a position in RMD in Q4 2016 and held it in 5 quarters. The position peaked at $1.7M in Q4 2017. 445 funds tracked by Wall St. Rank hold RMD as of Q1 2018.

  • Nikko Asset Management Americas reported no remaining ResMed position as of Q1 2018 after selling out during the quarter.
  • Nikko Asset Management Americas sold 22,100 ResMed shares in Q1 2018, an estimated $1.7M.
  • Nikko Asset Management Americas first reported a position in ResMed in Q4 2016 and held it in 5 quarters.
  • Nikko Asset Management Americas's ResMed position peaked at $1.7M in Q4 2017.
  • 445 funds tracked by Wall St. Rank held ResMed as of Q1 2018.

Based on Nikko Asset Management Americas's 13F filing for Q1 2018, filed 23 Apr 2018.